Tenderwize
Back to tender search

Open house Arzneimittelrabattverträge Naltrexon, ATC N07BB04

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline May 05, 2027 · 260 days left·Open·Supplies·Framework
Structured notice only
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Naltrexon, ATC N07BB04

40/100

Opportunity Score

Needs reviewLow complexity
SuppliesFrameworkOpen
Why this score?

Opportunity

40 / 100

Complexity

20 / 100

Risk factors

No estimated value or framework maximum is provided. The commercial attractiveness is unknown.

Open-house agreements automatically terminate if a formal procurement-based discount contract for Naltrexone is conclud...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Jun 2027
  • Non-exclusive discount agreements for Naltrexone (ATC N07BB04) under §130a Abs. 8 SGB V
  • Contract duration: July 1, 2025 to June 30, 2027
Show full summary

This is an open-house model (non-procurement) for non-exclusive discount agreements on Naltrexone (ATC N07BB04) with AOK Bayern. Any eligible pharmaceutical company can join by submitting a signed declaration of reliability and signed contract documents. The contract runs from July 1, 2025 to June 30, 2027. No estimated value is provided. The notice is published under procurement forms but is explicitly stated not to be a procurement procedure.

Risks

No estimated value or framework maximum is provided. The commercial attractiveness is unknown.

Open-house agreements automatically terminate if a formal procurement-based discount contract for Naltrexone is conclud...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Eligibility

  • Eligibility: only pharmaceutical companies may participate

Administrative

  • Submission of signed contract, annex listing covered medicines, and signed declaration of reliability
  • Documents can be submitted in paper (two originals) or electronically with qualified electronic signature

Requirements may be incomplete.

Award Criteria

Lot 1

No award criteria applicable since this is an open-house model with no selection process.

Buyer

Location

München, DEU

Website

www.aok.de

Buyer profile

Open profile

Identifier

DE811695320

Activity

Health

Lots (1)

LOT-0001

Open house Arzneimittelrabattverträge Naltrexon, ATC N07BB04

Non-exclusive discount agreements for the active substance Naltrexone (ATC N07BB04). Eligible pharmaceutical companies can join at any time until May 5, 2027. Contracts are identical and not negotiable. Early termination possible with one-month notice. The open-house agreements automatically cease if a nationwide or regional discount contract is concluded via a formal procurement procedure.

SuppliesFrameworkEU fundedElectronic submission

Location

DE212, Germany

Duration

Jun 2025 - Jun 2027

Category

Pharmaceutical products

Award Criteria

No award criteria applicable since this is an open-house model with no selection process.

Deadline

Deadline May 05, 2027

Procurement Details

Publication date
15 May 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
317360-2025

Documents (2)

Similar tenders